sorafenib has been researched along with artemisinin in 5 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (artemisinin) | Trials (artemisinin) | Recent Studies (post-2010) (artemisinin) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 2,825 | 132 | 1,682 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 4 (80.00) | 2.80 |
Authors | Studies |
---|---|
Liu, Y; Xu, Z; Zhao, SJ | 1 |
Barnoin, G; Bijani, C; Cuvillier, O; Fernandez Alvarez, A; Fortin, PY; Gornitzka, H; Hemmert, C; Maddelein, ML; Qin, X; Wang, X; Zhang, C | 1 |
Cai, N; Cheng, K; Liang, H; Wen, J; Xiong, Y; Zhang, W; Zhang, Y; Zhu, J | 1 |
Bentzen, SM; Civin, CI; Emadi, A; Fox, JM; Kim, M; Kingsbury, TJ; Lapidus, RG; McCullough, S; Moses, BS; Mott, BT; Rudek, MA; Tyner, JW | 1 |
Cui, Z; Jiang, T; Li, C; Li, L; Li, S; Ma, J; Qin, T; Shi, H; Tang, T; Wang, H; Xu, W; Zhou, H | 1 |
2 review(s) available for sorafenib and artemisinin
Article | Year |
---|---|
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |
The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors.
Topics: Acetaminophen; Antineoplastic Agents; Antioxidants; Apoptosis; Artemisinins; Auranofin; Cell Death; Cisplatin; Epigenesis, Genetic; Fatty Acids; Ferroptosis; Haloperidol; Humans; Indoles; Iron; Lapatinib; Mevalonic Acid; NADP; Neoplasms; Oxidation-Reduction; Oxidative Stress; Oxygen; Quinolines; Reactive Oxygen Species; Sorafenib; Spiro Compounds; Sulfasalazine; Trigonella | 2020 |
3 other study(ies) available for sorafenib and artemisinin
Article | Year |
---|---|
An Artemisinin-Derivative-(NHC)Gold(I) Hybrid with Enhanced Cytotoxicity through Inhibition of NRF2 Transcriptional Activity.
Topics: Antineoplastic Agents; Artemisinins; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gold; Hep G2 Cells; Humans; NF-E2-Related Factor 2; Sorafenib | 2020 |
Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax.
Topics: Artemisinins; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Drug Synergism; Humans; Sorafenib; Sulfonamides | 2021 |
Ferroptosis plays an essential role in the antimalarial mechanism of low-dose dihydroartemisinin.
Topics: Animals; Antimalarials; Artemisinins; Cell Death; Female; Ferroptosis; Humans; Malaria; Mice; Mice, Inbred C57BL; Parasites; Piperazines; Reactive Oxygen Species; Sorafenib | 2022 |